FCGR2A Promoter Methylation and Risks for Intravenous Immunoglobulin Treatment Responses in Kawasaki Disease.
about
Major methylation alterations on the CpG markers of inflammatory immune associated genes after IVIG treatment in Kawasaki diseaseMale-specific association of the FCGR2A His167Arg polymorphism with Kawasaki diseaseThe effect of FcγRIIA and FcγRIIB on coronary artery lesion formation and intravenous immunoglobulin treatment responses in children with Kawasaki disease.Prediction for Intravenous Immunoglobulin Resistance by Using Weighted Genetic Risk Score Identified From Genome-Wide Association Study in Kawasaki Disease.
P2860
FCGR2A Promoter Methylation and Risks for Intravenous Immunoglobulin Treatment Responses in Kawasaki Disease.
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
2015年论文
@zh
2015年论文
@zh-cn
name
FCGR2A Promoter Methylation an ...... Responses in Kawasaki Disease.
@ast
FCGR2A Promoter Methylation an ...... Responses in Kawasaki Disease.
@en
type
label
FCGR2A Promoter Methylation an ...... Responses in Kawasaki Disease.
@ast
FCGR2A Promoter Methylation an ...... Responses in Kawasaki Disease.
@en
prefLabel
FCGR2A Promoter Methylation an ...... Responses in Kawasaki Disease.
@ast
FCGR2A Promoter Methylation an ...... Responses in Kawasaki Disease.
@en
P2093
P2860
P50
P356
P1476
FCGR2A Promoter Methylation an ...... Responses in Kawasaki Disease
@en
P2093
Henry Sung-Ching Wong
Kai-Sheng Hsieh
Mei-Shin Wu
Peng Yeong Woon
Ruo-Kai Lin
Yu-Wen Hsu
P2860
P304
P356
10.1155/2015/564625
P577
2015-05-18T00:00:00Z